Microbiome Movement Drug Development Europe is a conference that covers topics such as:
- Definition of a Healthy Microbiome and If Disturbed – How to Shape It Back to Normal
- Studying Microbiome-Host Interactions to Translate Microbiome Drugs into the Clinic
- Microbiome in Understanding Human Biology, Disease and Diagnostics
- Functional Analysis of Microbial Communities
- Microbiome Research at NIBR: Microbial Metabolites That Modulate Host Functions
- Using Metagenomic Dataset Delivers Druggable Targets
- Delivery, Survival, Engraftment and Activity of LBPs in the Gastrointestinal Tract
- FMT-Based Discovery: From Platform to Product
- Preserving the Intestinal Microbiota during Antibiotic Treatments with DAV132: From Preclinical Studies in Hamsters to Phase 1 Trials in Humans
- Clinical Development of Ribaxamse, an Oral-Beta Lactamase Intended to Protect the Gut Microbiome and Prevent C.Diificile
- The Regulatory Challenge for Registering Live Biotherapeutic Products in Europe
- Clinical Considerations of Rationally Designed Live Bacterial Cocktails
- Oral Delivery of Live Bio-Therapeutics: Drug Product Development for FIM Studies
- Manufacturing the Microbiome – An Industry Perspective
- Modulating Human Microbiome: Bacteriophages and Their Practical Applications
- Novel Approaches for Microbiome Modulation Addressing IBD, Cancer and Acne
- Harnessing the Human Microbiome to Influence the Development of Cancer
- Novel Approaches to an Ancient Therapeutic Strategy
- Harnessing the Vaginal Microbiome in Contraceptive Development
- Oral Polyclonal Antibodies as Targeted Gut Microbiome Modulators
- The Microbiome: Translating Research into Discovery
Microbiome Movement Drug Development Europe might be held in Jan 2024.
